About this trial
The goal of this study type: clinical trial\] is to learn the effect of Botulinum Toxin \_A injection in treatment of RT1andRT2 Gingival recession in lower anterior teeth .
Primary outcome is keratinzed tissue width. Researchers will compare Coronally Advanced flap with De-epithelized free gingival graft and Botulinum toxin-A injection in Mentalis muscle with coronally advanced flap with De-epithelized free gingival graft alone .
The outcome will be measured at baseline, after 3 months and after 6 mobths \_medical history
* 3 mm horizontal incisions, then two vertical incisions * deepitheliztion of anatomical papillae * superficial and deep incisions * harvesting DFGG * Suturing * BOTOX injection
Eligibility criteria
Qualifiers
Single or multiple RT1, RT2 GR patient
patients ≥18 years
systemically healthy, full mouth plaque score, full mouth bleeding score ≤ 15% after phase I therapy
clinical indication and/or patient request for recession coverage
Disqualifiers
Pregnant or lactating women
Smokers' patients
Teeth with cervical restorations/abrasion.
Patients had a systemic condition affect blood components and healing
Trial design
Treatments tested in this trial
- Botulinum toxin-A injection
- Coronally advanced flap